FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Infinium Pharmachem IPO and MOS Utility IPO.
Infinium Pharmachem IPO is a SME Book Built Issue IPO proposed to list at NSE SME while MOS Utility IPO is a SME Book Built Issue proposed to list at NSE SME.
Infinium Pharmachem IPO | MOS Utility IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price Issue | Book Built Issue |
Listing At | NSE SME | NSE SME |
Lead Managers | Swastika Investmart Ltd | Unistone Capital Pvt Ltd |
Registrar | Bigshare Services Pvt Ltd | Skyline Financial Services Private Ltd |
Market Maker | Swastika Investmart Limited | Rikhav Securities Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Infinium Pharmachem IPO is up to ₹25.26 Cr whereas the issue size of the MOS Utility IPO is up to ₹49.97 Cr. The final issue price of Infinium Pharmachem IPO is ₹135.00 per share and of MOS Utility IPO is ₹76.00 per share.
Infinium Pharmachem IPO | MOS Utility IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹72.00 per share | |
Issue Price (Upper) | ₹76.00 per share | |
Issue Price (Final) | ₹135.00 per share | ₹76.00 per share |
Discount (Retail) | ||
Discount (Employee) | ₹13.50 per share | |
Market Lot Size | 1000 shares | 1600 shares |
Fresh Issue Size | 18,75,000 shares | 57,74,400 shares |
Fresh Issue Size (Amount) | up to ₹25.26 Cr | up to ₹43.89 Cr |
OFS Issue Size | 8,00,000 shares | |
OFS Issue Size (Amount) | up to ₹6.08 Cr | |
Issue Size Total | 18,75,000 shares | 65,74,400 shares |
Issue Size Total (Amount) | up to ₹25.26 Cr | up to ₹49.97 Cr |
Infinium Pharmachem IPO opens on Mar 31, 2023, while MOS Utility IPO opens on Mar 31, 2023. The closing date of Infinium Pharmachem IPO and MOS Utility IPO is Apr 05, 2023, and Apr 06, 2023, respectively.
Infinium Pharmachem IPO | MOS Utility IPO | |
---|---|---|
Anchor Bid Date | Mar 29, 2023 | |
Issue Open | Mar 31, 2023 | Mar 31, 2023 |
Issue Close | Apr 05, 2023 | Apr 06, 2023 |
Basis Of Allotment (Tentative) | Apr 11, 2023 | Apr 12, 2023 |
Initiation of Refunds (Tentative) | Apr 12, 2023 | Apr 13, 2023 |
Credit of Share (Tentative) | Apr 13, 2023 | Apr 17, 2023 |
Listing date (Tentative) | Apr 17, 2023 | Apr 18, 2023 |
Anchor Lockin End date 1 | May 11, 2023 | May 12, 2023 |
Anchor Lockin End date 2 | Jul 10, 2023 | Jul 11, 2023 |
Infinium Pharmachem IPO P/E ratio is 7.83, as compared to MOS Utility IPO P/E ratio of 48.41.
Infinium Pharmachem IPO | MOS Utility IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100% | 82.91% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 73.05% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 7.83 | 48.41 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹93.93 Cr. | ₹189.51 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 14.06%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 11.26%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.45 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Infinium Pharmachem IPO retail investors (RII) are offered 9,37,500 shares while in MOS Utility IPO retail investors are offered 9,37,500 shares. Qualified institutional buyers (QIB) are offered 0 shares in Infinium Pharmachem IPO and 15,23,200 shares in MOS Utility IPO.
Infinium Pharmachem IPO | MOS Utility IPO | |
---|---|---|
Anchor Investor Reserveration | 15,98,400 shares | |
Market Maker Reserveration | 94,000 shares | 3,29,600 shares |
QIB | 0 shares | 15,23,200 shares |
NII | 9,37,500 shares | 9,37,600 shares |
RII | 9,37,500 shares | 21,85,600 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 18,75,000 shares | 46,46,400 shares |
Infinium Pharmachem IPO subscribed 1.84x in total, whereas MOS Utility IPO subscribed 21.14x.
Infinium Pharmachem IPO | MOS Utility IPO | |
---|---|---|
QIB (times) | 11.67x | |
NII (times) | 1.80x | 57.90x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 1.86x | 11.98x |
Employee (times) | ||
Other (times) | ||
Total (times) | 1.84x | 21.14x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|